Management report as at 30 June 2020
Notes to the individual financial report as at 30 June 2020
Individual financial report according to IFRS as at 30 June 2020
„Sopharma“ AD starts the payment of the gross dividend on August 3, 2020
Notification for technical error correction
Sofia, Bulgaria, July 7, 2020 „Sopharma” AD (3JR: “BSE-Sofia” AD, SPH: Warsaw Stock Exchange) notifies that the text „art. 111, para. 8 of LPOS“, should be replaced with the text „art.
Sales revenues for June 2020
Sofia, Bulgaria, July 6, 2020 – “Sopharma” AD (3JR: “BSE-Sofia” AD, SPH: Warsaw Stock Exchange) notifies that for June 2020 the Company recorded a decrease in sales of 5% compared to the same month of 2019, incl. 78% decrease in domestic sales and 59% increase in export sales.
In the first half of 2020 the revenues from sales of production increase by 1% compared to the same period of 2019, incl. 19% decrease of sales for the domestic market and 13% increase in export sales.
Notification for acquisition of own shares
Sofia, Bulgaria, July 1, 2020 - Sopharma AD (3JR: “BSE-Sofia” AD, SPH: Warsaw Stock Exchange) notifies that on June 30, 2020 the Company sold 12 000 own shares representing 0.0089% of the share capital of the Company, at a total value of BGN 37 950 on the Bulgarian Stock Exchange, the average price per share was 3.1625 BGN.
The total number of treasury shares after this transaction is 8 974 467, representing 6.658% of the share capital of the Company.